Current status of Raf Kinase Inhibitor Protein (RKIP) in lung cancer: behind RTK signaling

Lung cancer is the most deadly neoplasm with the highest incidence in both genders, with non-small cell lung cancer (NSCLC) being the most frequent subtype. Somatic mutations within the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene are key drivers of NSCLC progression, w...

Full description

Bibliographic Details
Main Author: Raquel-Cunha, Ana (author)
Other Authors: Cardoso-Carneiro, Diana (author), Reis, R. M. (author), Martinho, Olga (author)
Format: article
Language:eng
Published: 2019
Subjects:
lung cancer
EGFR
RKIP signaling
prognosis
cancer therapy
Science & Technology
Online Access:http://hdl.handle.net/1822/60805
Country:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/60805

Internet

http://hdl.handle.net/1822/60805

Similar Items